Table 2. Age adjusted estimates for clinical characteristics related to metabolic syndrome by sex and race/ethnicity, adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), The National Health and Nutrition Examination Survey (NHANES III) 1988–1994 (n = 3,080).
| Clinical Characteristics | Males | Females | ||||
|---|---|---|---|---|---|---|
| White, non-Hispanics | Black, non-Hispanics | Mexican Americans | White, non-Hispanics | Black, non-Hispanics | Mexican Americans | |
| (n = 1,961) | (n = 1,351) | (n = 1,553) | (n = 2,323) | (n = 1,790) | (n = 1,627) | |
| Number of Metabolic Abnormalities†, Mean (SE) | 1.8 (0.04) | 1.5 (0.04) * | 1.9 (0.05) * | 1.5 (0.06) | 1.8 (0.03) * | 2.1 (0.03) * |
| Metabolic Syndrome‡, % (SE) | 27.9 (0.01) | 21.4 (0.01) * | 31.1 (0.01) | 23.7 (0.01) | 27.7 (0.01) * | 35.6 (0.01) * |
| Central Obesity, % (SE) | 31.1 (0.01) | 26.6 (0.01) * | 31.1 (0.02) | 40.8 (0.01) | 59.5 (0.01) * | 60.4 (0.01) * |
| Waist Circumference (inches), Mean (SE) | 96.6 (0.3) | 93.3 (0.3) * | 96.1 (0.4) | 87.7 (0.5) | 93.9 (0.5) * | 93.1 (0.4) * |
| Hypertriglyceridemia, % (SE) | 40.8 (0.02) | 27.0 (0.01) * | 47.4 (0.02) * | 26.7 (0.01) | 19.6 (0.01) * | 39.6 (0.01) * |
| Triglyceridemia (mg/dL), Mean (SE) | 161.0 (3.9) | 128.5 (2.6) * | 182.1 (4.4) * | 130.8 (3.4) | 111.1 (2.0) * | 153.8 (3.2) * |
| Hypertension, % (SE) | 38.0 (0.01) | 46.1(0.01) * | 36.8 (0.01) | 30.3 (0.01) | 43.3 (0.01) * | 35.5 (0.01) * |
| SBP (mmHg), Mean (SE) | 106.1 (0.8) | 108.6 (0.8) * | 106.0 (0.8) | 87.3 (0.6) | 93.1 (0.6) * | 89.8 (0.6) * |
| Dyslipidemia, % (SE) | 38.2 (0.02) | 24.2 (0.01) * | 37.4 (0.02) | 38.5 (0.02) | 36.3 (0.01) | 47.8 (0.02) * |
| HDL (mg/dL), Mean (SE) | 44.8 (0.5) | 52.1 (0.5) * | 45.3 (0.5) | 55.6 (0.6) | 57.1 (0.5) * | 52.1 (0.5) * |
| Hyperglycemia, % (SE) | 30.4 (0.01) | 30.4 (0.01) | 38.2 (0.02) * | 17.8 (0.01) | 25.9 (0.01) * | 30.5 (0.01) * |
| Plasma Glucose (mg/dL), Mean (SE) | 100.1 (0.6) | 101.9 (0.8) | 105.8 (0.9) * | 95.1 (0.7) | 102.0 (1.5) * | 102.2 (0.7) * |
HDL, High-Density Lipoprotein Cholesterol; SBP, Systolic Blood Pressure
* P-value <0.05 for adults of the same sex in reference to white non-Hispanics
† (1) hyperglycemia (i.e., fasting blood glucose over 100 mg/dl, or pharmacological treatment), (2) dyslipidemia (i.e., fasting HDL cholesterol level less than 40 mg/dl, men, or 50 mg/dl, women, or pharmacological treatment) (3) hypertriglyceridemia (i.e., fasting triglyceride (TG) level over 150 mg/dl, or pharmacological treatment), (4) central obesity (i.e., waist circumference over 40 inches, men, or 35 inches, women), or (5) hypertension (i.e., systolic blood pressure (SBP) over 130 mmHg, or pharmacological treatment)
‡ Three or more metabolic abnormalities